Insider Transactions in Q2 2025 at Rapport Therapeutics, Inc. (RAPP)
Insider Transaction List (Q2 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Apr 15
2025
|
David Bredt Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,500
-1.81%
|
$76,500
$9.57 P/Share
|